Diabetes is associated with increased renal production of vasodilator prostaglandins [ 1,2], which is postulated to mediate the hyperfiltration associated with the disease. While this hypothesis has been strengthened by the evidence that prostaglandin synthetase (PGS) inhibitors, lysine acetylsalicylate [3] & piroxicam [4], reduced the increased glomerular filtration rate (GFR) found in diabetic patients, other workers have found conflicting results [5]. A possible explanation for this discrepancy is that other eicosanoids, in addition to vasodilatory prostaglandins,are responsible for the altered renal haemodynamics associated with diabetes. Indeed we have previously shown that the kidney has high levels of lipoxygenase activity [6], which has the potential to generate other eicosanoids. We therefore decided to investigate renal lipoxygenase activity in diabetic rats.Sprague-Dawley rats were administered a single dose of streptozotocin (STZ) (45 mg/kg). The presence of diabetes was established 24 h later by the presence of frank glycosuria and polyuria. After 5 days, the rats were anaesthetised and blood removed by cardiac puncture. After cervical dislocation, kidneys were removed and subcellular fractions prepared.Blood analysis showed increased levels of glucose in the STZtreated animals compared with controls (29.9k3.1 ~s 8.3f1.2 mmoV1, n=4, ~4 . 0 1 ) . Similarly, creatinine levels increased in STZ-treated animals (75+6 ~s 53fl pnoUl, p<0.05), indicating impairment of glomerular function.Significantly higher levels of reduced glutathione (GSH) were observed in kidney cytosol from diabetic animals (107.4f31.6 ~s 5 1.8f1.8 nmolhg; p4.05). This elevated level of glutathione may be a protective mechanism since in diabetes, the levels of other antioxidants are reduced [7,8].PGS and lipoxygenase (LO) activity can be measured by investigation of the arachidonic acid (AA)-dependent metabolism of the model compound tetramethylphenylenediamine (TMPD) [9]. In the present study, we found that addition of AA (100p.M) caused a greater stimulation of activity in microsomes prepared from STZ-treated rats (16.8k2.1 nmol TMPD oxidisedmidmg) than that from controls (12.7M.7 nmoUmin/mg). The greater stimulation of AA-dependent activity in STZ-treated rats compared with controls (p